Literature DB >> 17123494

Human leukocytes express ephrinB2 which activates microvascular endothelial cells.

David O Zamora1, Bobby Babra, Yuzhen Pan, Stephen R Planck, James T Rosenbaum.   

Abstract

EphrinB2-EphB4 interaction modulates the migration/adhesion of various cell types, including endothelial cells (EC) and peripheral blood leukocytes (PBLs). We hypothesize that the Ephrin/Eph signaling mechanism plays a role in mediating EC/leukocyte interactions during inflammation. PBLs were isolated from human blood, stimulated with inflammatory mediators, and total RNA or protein assayed for EphrinB2 expression. PBLs demonstrated differential expression profiles of EphrinB2 mRNA or protein, depending on cell subtype and stimulus. Human iris tissue and iris EC (HIEC) were examined for the expression of EphB4 mRNA and protein. Some blood vessels were EphB4(+), while stimulation of purified HIEC did not alter their expression of EphB4. HIEC treated with sEphrinB2/Fc from 0 to 60min did exhibit changes in their phospho-Erk1/2 levels. These observations indicate that stimulated lymphocytes express EphrinB2, which has the potential to activate EC. This suggests a novel mechanism by which EC and lymphocytes communicate to regulate cell activation/migration during inflammation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17123494     DOI: 10.1016/j.cellimm.2006.10.001

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  7 in total

1.  Eph/ephrin-B-mediated cell-to-cell interactions govern MTS20(+) thymic epithelial cell development.

Authors:  Sara Montero-Herradón; Javier García-Ceca; Beatriz Sánchez Del Collado; David Alfaro; Agustín G Zapata
Journal:  Histochem Cell Biol       Date:  2016-04-09       Impact factor: 4.304

2.  Treatment with ephrin B2 positively impacts the abnormal metabolism of human osteoarthritic chondrocytes.

Authors:  Steeve Kwan Tat; Jean-Pierre Pelletier; Nathalie Amiable; Christelle Boileau; Martin Lavigne; Johanne Martel-Pelletier
Journal:  Arthritis Res Ther       Date:  2009-08-07       Impact factor: 5.156

3.  Soluble EphB4 inhibition of PDGF-induced RPE migration in vitro.

Authors:  Shikun He; S Ram Kumar; Peng Zhou; Valery Krasnoperov; Stephen J Ryan; Parkash S Gill; David R Hinton
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-08-20       Impact factor: 4.799

4.  Inhibition of EphA2 by Dasatinib Suppresses Radiation-Induced Intestinal Injury.

Authors:  Areumnuri Kim; Ki Moon Seong; You Yeon Choi; Sehwan Shim; Sunhoo Park; Seung Sook Lee
Journal:  Int J Mol Sci       Date:  2020-11-30       Impact factor: 5.923

5.  Inhibition of choroidal neovascularization by anti-EphB4 monoclonal antibody.

Authors:  Dongfeng Su; Xiaoqiu Li; Dianwen Gao
Journal:  Exp Ther Med       Date:  2013-02-18       Impact factor: 2.447

6.  The multidrug-resistance transporter Abcc3 protects NK cells from chemotherapy in a murine model of malignant glioma.

Authors:  Sara Pessina; Gabriele Cantini; Dimos Kapetis; Emanuela Cazzato; Natalia Di Ianni; Gaetano Finocchiaro; Serena Pellegatta
Journal:  Oncoimmunology       Date:  2015-10-29       Impact factor: 8.110

Review 7.  Ephs and Ephrins in Adult Endothelial Biology.

Authors:  Dianne Vreeken; Huayu Zhang; Anton Jan van Zonneveld; Janine M van Gils
Journal:  Int J Mol Sci       Date:  2020-08-06       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.